OpenSAFELY Vaccine Coverage Report

AstraZeneca / Priority Group 3

Data from combined, up to 2021-03-20.

Vaccinated at 2021-03-20 (%) Vaccinated at 2021-03-20 (n) Population Vaccinated at 2021-03-13 (%) Vaccinated in past week (%)
Overall - 48.7% 959,980 1,970,192 48.6% 0.1%
Sex Female 48.8% 512,743 1,049,629 48.7% 0.1%
Male 48.6% 447,237 920,563 48.5% 0.1%
Ethnicity White - British 49.7% 600,733 1,208,025 49.6% 0.1%
White - Irish 43.2% 7,217 16,688 43.0% 0.2%
White - Any other White background 39.6% 17,080 43,120 39.4% 0.2%
Mixed - White and Black Caribbean 39.9% 861 2,156 39.6% 0.3%
Mixed - White and Black African 38.0% 434 1,141 37.4% 0.6%
Mixed - White and Asian 39.8% 518 1,302 39.8% 0.0%
Mixed - Any other mixed background 40.1% 910 2,268 39.5% 0.6%
Asian or Asian British - Indian 39.7% 10,150 25,543 39.5% 0.3%
Asian or Asian British - Pakistani 41.0% 4,340 10,584 40.1% 0.9%
Asian or Asian British - Bangladeshi 43.5% 1,267 2,912 42.5% 1.0%
Asian or Asian British - Any other Asian background 37.2% 4,256 11,438 37.0% 0.2%
Black or Black British - Caribbean 36.3% 4,151 11,424 35.6% 0.7%
Black or Black British - African 32.1% 2,576 8,036 31.3% 0.8%
Black or Black British - Any other Black background 35.2% 616 1,750 34.8% 0.4%
Other ethnic groups - Chinese 36.8% 1,169 3,178 36.3% 0.4%
Other ethnic groups - Any other ethnic group 40.1% 2,555 6,377 39.6% 0.4%
Patients with any other ethnicity code 49.3% 136,157 276,339 49.2% 0.1%
Ethnicity not stated 48.3% 5,656 11,718 48.1% 0.1%
Ethnicity not recorded 48.8% 159,236 326,088 48.7% 0.1%
Ethnicity (broad categories) White 49.3% 625,044 1,267,847 49.2% 0.1%
Mixed 39.7% 2,737 6,888 39.4% 0.3%
South Asian 39.7% 20,027 50,498 39.2% 0.4%
Black 34.7% 7,357 21,231 34.0% 0.7%
Other 39.0% 3,731 9,555 38.6% 0.4%
Unknown 49.0% 301,056 614,152 48.9% 0.1%
Index of Multiple Deprivation 1 (most deprived) 47.7% 123,879 259,721 47.4% 0.3%
2 47.1% 156,667 332,640 46.9% 0.2%
3 48.8% 204,750 419,454 48.7% 0.1%
4 49.0% 225,232 459,669 48.9% 0.1%
5 (least deprived) 49.9% 241,437 483,392 49.9% 0.1%
Unknown 52.2% 7,987 15,288 52.2% 0.1%
Clinical Risk Groups Patients in Any Clinical Risk Group 49.5% 573,783 1,159,410 49.3% 0.1%
Patients with Immunosuppression 49.3% 42,238 85,743 49.1% 0.1%
Patients with CKD 49.7% 160,538 323,316 49.5% 0.1%
Patients who have Chronic Respiratory Disease 50.4% 113,022 224,168 50.3% 0.2%
Patients with Diabetes 49.2% 180,663 367,003 49.0% 0.2%
Patients with Chronic Liver disease 48.7% 25,431 52,178 48.6% 0.1%
Patients with CNS Disease (including Stroke/TIA) 51.8% 110,327 212,828 51.6% 0.2%
Patients with Chronic heart disease 49.8% 294,448 590,891 49.7% 0.1%
Patients with Asplenia or Dysfunction of the Spleen 49.5% 8,470 17,122 49.4% 0.1%
Patients with Wider Learning Disability 58.7% 1,365 2,324 57.8% 0.9%
Patients with Severe Mental Health 51.8% 8,162 15,750 51.3% 0.5%
Other Groups Patients who are shielding (High Risk from COVID-19) 49.9% 153,314 307,188 49.7% 0.2%
Patients with Morbid Obesity 51.8% 24,724 47,698 51.6% 0.2%
Patients who are pregnant 53.1% 119 224 53.1% 0.0%